119139 Adenosine A₃ Receptor Agonist, 2-Cl-IB-MECA - CAS 163042-96-4 - Calbiochem

119139
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical FormulaCAS #
C₁₈H₁₈ClIN₆O₄ 163042-96-4

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
119139-2MGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 2 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewAn adenosine analog that acts as a highly selective agonist of adenosine A3 receptor (Ki = 330 pM, 820 nM, 470 nM for A3, A1 and A2A, respectively). Shown to reduce ischemia reperfusion injury in mice and limit infarct size in isolated rat hearts. Shown to reversibly increase field excitatory postsynaptic potentials in hippocampal slices and exhibits excitatory effects on both evoked and spontaneous epileptiform discharges.
      Catalogue Number119139
      Brand Family Calbiochem®
      Synonyms2-Cl-IB-MECA, 2-chloro-IB-MECA
      References
      ReferencesKim, H. O., et al. 1994. J Med Chem. 37, 3614.
      Laudadio, M. A., et al. 2004. Epilepsy Res. 59, 83.
      Ge, Z.D., et al. 2006. J. Pharm. Exp. Ther. 319, 1200.
      Product Information
      CAS number163042-96-4
      FormWhite solid
      Hill FormulaC₁₈H₁₈ClIN₆O₄
      Chemical formulaC₁₈H₁₈ClIN₆O₄
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Adenosine A₃ Receptor Agonist, 2-Cl-IB-MECA - CAS 163042-96-4 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Adenosine A₃ Receptor Agonist, 2-Cl-IB-MECA - CAS 163042-96-4 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      119139

      参考資料

      参考資料の概要
      Kim, H. O., et al. 1994. J Med Chem. 37, 3614.
      Laudadio, M. A., et al. 2004. Epilepsy Res. 59, 83.
      Ge, Z.D., et al. 2006. J. Pharm. Exp. Ther. 319, 1200.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-April-2014 JSW
      Synonyms2-Cl-IB-MECA, 2-chloro-IB-MECA
      DescriptionAn adenosine analog that acts as a highly selective agonist of adenosine A3 receptor (Ki = 330 pM, 820 nM, 470 nM for A3, A1 and A2A, respectively). Shown to reduce ischemia reperfusion injury in mice and limit infarct size in isolated rat hearts. Shown to reversibly increase field excitatory postsynaptic potentials in hippocampal slices and exhibits excitatory effects on both evoked and spontaneous epileptiform discharges.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number163042-96-4
      Chemical formulaC₁₈H₁₈ClIN₆O₄
      Purity≥98% by HPLC
      SolubilityDMSO (20 mg/ml)
      Storage -20°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesKim, H. O., et al. 1994. J Med Chem. 37, 3614.
      Laudadio, M. A., et al. 2004. Epilepsy Res. 59, 83.
      Ge, Z.D., et al. 2006. J. Pharm. Exp. Ther. 319, 1200.